On Feb. 21, 2022, China National Medical Products Administration (NMPA) issued the finalized Measures for the Management of Cosmetic Adverse Reaction Monitoring (Measures), which will be implemented on Oct. 1, 2022. The Measures stipulates that cosmetic stakeholders (e.g. registrant, notifier, manufacturers, and operators) should take the initiative to collect and report adverse reactions of cosmetics through National Cosmetic Adverse Reaction Monitoring System, and cooperate with relevant regulatory authorities to investigate and handle the adverse reactions.
The Measures also clarifies the responsibilities and obligations of cosmetic stakeholders, and the detailed requirements for each stage in the monitoring and reporting of adverse reactions. Welcome to visit ChemLinked News for more details.
On Sep. 20, 2022, China NMPA issued an announcement stating that it will launch the upgraded new version of the National Cosmetic Adverse Reaction Monitoring System (hereinafter referred to as "system") on Oct. 1, 2022. 1 Detailed information is as follows.